Entry - #616482 - ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN - OMIM
# 616482

ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN


Alternative titles; symbols

SADDAN DYSPLASIA


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
4p16.3 SADDAN 616482 AD 3 FGFR3 134934
Clinical Synopsis
 

INHERITANCE
- Autosomal dominant
GROWTH
Height
- Dwarfism
- Short stature, severe disproportionate
HEAD & NECK
Head
- Megalencephaly
- Large anterior fontanel
Face
- Midface hypoplasia
- Frontal bossing
Ears
- Hearing loss, mild-to-moderate
- Otitis media
Eyes
- Exotropia (in some patients)
- High myopia (in some patients)
Nose
- Depressed nasal bridge
CARDIOVASCULAR
Heart
- Congestive heart failure (in some patients)
Vascular
- Pulmonary hypertension (in some patients)
RESPIRATORY
- Respiratory compromise at birth
- Sleep apnea
CHEST
External Features
- Small chest with flaring costal margins
ABDOMEN
Gastrointestinal
- Gastroesophageal reflux (in some patients)
SKELETAL
Skull
- Overgrowth of mandible in adults
- Pneumatization of the sinuses
Spine
- Platyspondyly
- Kyphosis
- Lumbar lordosis
- Cervical spinal stenosis
Pelvis
- Posterior rotation of hips
Limbs
- Rhizomelia
- Mesomelia
- Anterior bowing of femora
- Posterior bowing of tibiae
SKIN, NAILS, & HAIR
Skin
- Redundant skin folds on upper and lower limbs
- Acanthosis nigricans
NEUROLOGIC
Central Nervous System
- Seizures
- Hydrocephalus
- Central apnea
- Developmental delay
- Limited language acquisition
- Mental retardation, moderate to profound
- Thin corpus callosum
MISCELLANEOUS
- Clinical overlap with thanatophoric dysplasia I (187600) and severe achondroplasia (100800)
MOLECULAR BASIS
- Caused by mutation in the fibroblast growth factor receptor-3 gene (FGFR3, 134934.0015)

TEXT

A number sign (#) is used with this entry because of evidence that severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is caused by heterozygous mutation in the gene encoding fibroblast growth factor receptor-3 (FGFR3; 134934) on chromosome 4p16.


Description

SADDAN dysplasia (severe achondroplasia with developmental delay and acanthosis nigricans) is a very rare skeletal dysplasia characterized by the constellation of these features. Radiology reveals 'ram's horn' shaped clavicles and reverse bowing of lower limbs. Approximately half of patients die before the fourth week of life secondary to respiratory failure (summary by Zankl et al., 2008).


Clinical Features

Tavormina et al. (1999) reported 4 unrelated individuals with a distinctive syndrome comprising severe achondroplasia with developmental delay and acanthosis nigricans, which they referred to as SADDAN dysplasia. Two of the patients had previously been reported in an abstract (Francomano et al., 1996). The severity approached that observed in thanatophoric dysplasia type I (TD1; 187600). Differences included the development of extensive areas of acanthosis nigricans beginning in early childhood in 3 of 4 patients, severe neurologic impairments, and survival past infancy without prolonged life-support measures. Bellus et al. (1999) described in detail the clinical and radiographic features of these patients.

Zankl et al. (2008) reported a patient with the SADDAN phenotype. He had severe micromelia, frontal bossing, large anterior fontanel, depressed nasal bridge, reverse tibial bowing, small thorax, and hypotonia. Acanthosis nigricans was not present. He died at age 21 days due to respiratory failure. Zankl et al. (2008) noted that about half of patients reported with the K650M mutation died before 21 days of age, whereas others have shown longer survival. The authors also noted that acanthosis nigricans has been reported in patients with other skeletal dysplasias due to FGFR3 mutations, and thus should be considered a long-term complication rather than a specific feature of SADDAN. In addition, mental retardation only becomes apparent in long-term survivors and thus cannot be used as a diagnostic criterion for SADDAN in the neonatal period.


Molecular Genetics

In 4 unrelated patients with SADDAN dysplasia, Tavormina et al. (1999) identified a heterozygous mutation in the FGFR3 gene (K650M; 134934.0015), resulting in a dramatic increase in constitutive receptor kinase activity.

In a patient with SADDAN dysplasia, Zankl et al. (2008) identified heterozygosity for the K650M mutation in the FGFR3 gene.


Animal Model

Iwata et al. (2001) introduced the murine equivalent (K644M) of the human SADDAN point mutation (K650M; 134934.0015) into the mouse Fgfr3 gene. Heterozygous mutant mice showed a phenotype similar to human SADDAN, e.g., the majority of the SADDAN mice survived the perinatal period. The long bone abnormalities in SADDAN mice were milder than the TDII model. In addition, overgrowth of the cartilaginous tissues was observed in the rib cartilage, trachea, and nasal septum. Unlike the TDII model, FGF ligands at low concentrations differentially activated Map kinase in primary chondrocyte cultures from wildtype and SADDAN mice.


REFERENCES

  1. Bellus, G. A., Bamshad, M. J., Przylepa, K. A., Dorst, J., Lee, R. R., Hurko, O., Jabs, E. W., Curry, C. J. R., Wilcox, W. R., Lachman, R. S., Rimoin, D. L., Francomano, C. A. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a lys650met mutation in fibroblast growth factor receptor 3. Am. J. Med. Genet. 85: 53-65, 1999. [PubMed: 10377013, related citations]

  2. Francomano, C. A., Bellus, G. A., Szabo, J., McIntosh, I., Dorst, J., Lee, R., Hurko, O., Fraley, A. E., Bamshad, M. J. A new skeletal dysplasia with severe tibial bowing, profound developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in fibroblast growth factor receptor 3 (FGFR3). (Abstract) Am. J. Hum. Genet. 59 (suppl.): A25 only, 1996.

  3. Iwata, T., Li, C.-L., Deng, C.-X., Francomano, C. A. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum. Molec. Genet. 10: 1255-1264, 2001. [PubMed: 11406607, related citations] [Full Text]

  4. Tavormina, P. L., Bellus, G. A., Webster, M. K., Bamshad, M. J., Fraley, A. E., McIntosh, I., Szabo, J., Jiang, W., Jabs, E. W., Wilcox, W. R., Wasmuth, J. J., Donoghue, D. J., Thompson, L. M., Francomano, C. A. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a lys650-to-met mutation in the fibroblast growth factor receptor 3 gene. Am. J. Hum. Genet. 64: 722-731, 1999. [PubMed: 10053006, related citations] [Full Text]

  5. Zankl, A., Elakis, G., Susman, R. D., Inglis, G., Gardener, G., Buckley, M. F., Roscioli, T. Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 lys650met mutation. Am. J. Med. Genet. 146A: 212-218, 2008. [PubMed: 18076102, related citations] [Full Text]


Creation Date:
Carol A. Bocchini : 7/24/2015
alopez : 06/16/2023
carol : 07/26/2015
carol : 7/24/2015

# 616482

ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN


Alternative titles; symbols

SADDAN DYSPLASIA


ORPHA: 85165;   DO: 0111158;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
4p16.3 SADDAN 616482 Autosomal dominant 3 FGFR3 134934

TEXT

A number sign (#) is used with this entry because of evidence that severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is caused by heterozygous mutation in the gene encoding fibroblast growth factor receptor-3 (FGFR3; 134934) on chromosome 4p16.


Description

SADDAN dysplasia (severe achondroplasia with developmental delay and acanthosis nigricans) is a very rare skeletal dysplasia characterized by the constellation of these features. Radiology reveals 'ram's horn' shaped clavicles and reverse bowing of lower limbs. Approximately half of patients die before the fourth week of life secondary to respiratory failure (summary by Zankl et al., 2008).


Clinical Features

Tavormina et al. (1999) reported 4 unrelated individuals with a distinctive syndrome comprising severe achondroplasia with developmental delay and acanthosis nigricans, which they referred to as SADDAN dysplasia. Two of the patients had previously been reported in an abstract (Francomano et al., 1996). The severity approached that observed in thanatophoric dysplasia type I (TD1; 187600). Differences included the development of extensive areas of acanthosis nigricans beginning in early childhood in 3 of 4 patients, severe neurologic impairments, and survival past infancy without prolonged life-support measures. Bellus et al. (1999) described in detail the clinical and radiographic features of these patients.

Zankl et al. (2008) reported a patient with the SADDAN phenotype. He had severe micromelia, frontal bossing, large anterior fontanel, depressed nasal bridge, reverse tibial bowing, small thorax, and hypotonia. Acanthosis nigricans was not present. He died at age 21 days due to respiratory failure. Zankl et al. (2008) noted that about half of patients reported with the K650M mutation died before 21 days of age, whereas others have shown longer survival. The authors also noted that acanthosis nigricans has been reported in patients with other skeletal dysplasias due to FGFR3 mutations, and thus should be considered a long-term complication rather than a specific feature of SADDAN. In addition, mental retardation only becomes apparent in long-term survivors and thus cannot be used as a diagnostic criterion for SADDAN in the neonatal period.


Molecular Genetics

In 4 unrelated patients with SADDAN dysplasia, Tavormina et al. (1999) identified a heterozygous mutation in the FGFR3 gene (K650M; 134934.0015), resulting in a dramatic increase in constitutive receptor kinase activity.

In a patient with SADDAN dysplasia, Zankl et al. (2008) identified heterozygosity for the K650M mutation in the FGFR3 gene.


Animal Model

Iwata et al. (2001) introduced the murine equivalent (K644M) of the human SADDAN point mutation (K650M; 134934.0015) into the mouse Fgfr3 gene. Heterozygous mutant mice showed a phenotype similar to human SADDAN, e.g., the majority of the SADDAN mice survived the perinatal period. The long bone abnormalities in SADDAN mice were milder than the TDII model. In addition, overgrowth of the cartilaginous tissues was observed in the rib cartilage, trachea, and nasal septum. Unlike the TDII model, FGF ligands at low concentrations differentially activated Map kinase in primary chondrocyte cultures from wildtype and SADDAN mice.


REFERENCES

  1. Bellus, G. A., Bamshad, M. J., Przylepa, K. A., Dorst, J., Lee, R. R., Hurko, O., Jabs, E. W., Curry, C. J. R., Wilcox, W. R., Lachman, R. S., Rimoin, D. L., Francomano, C. A. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a lys650met mutation in fibroblast growth factor receptor 3. Am. J. Med. Genet. 85: 53-65, 1999. [PubMed: 10377013]

  2. Francomano, C. A., Bellus, G. A., Szabo, J., McIntosh, I., Dorst, J., Lee, R., Hurko, O., Fraley, A. E., Bamshad, M. J. A new skeletal dysplasia with severe tibial bowing, profound developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in fibroblast growth factor receptor 3 (FGFR3). (Abstract) Am. J. Hum. Genet. 59 (suppl.): A25 only, 1996.

  3. Iwata, T., Li, C.-L., Deng, C.-X., Francomano, C. A. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum. Molec. Genet. 10: 1255-1264, 2001. [PubMed: 11406607] [Full Text: https://doi.org/10.1093/hmg/10.12.1255]

  4. Tavormina, P. L., Bellus, G. A., Webster, M. K., Bamshad, M. J., Fraley, A. E., McIntosh, I., Szabo, J., Jiang, W., Jabs, E. W., Wilcox, W. R., Wasmuth, J. J., Donoghue, D. J., Thompson, L. M., Francomano, C. A. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a lys650-to-met mutation in the fibroblast growth factor receptor 3 gene. Am. J. Hum. Genet. 64: 722-731, 1999. [PubMed: 10053006] [Full Text: https://doi.org/10.1086/302275]

  5. Zankl, A., Elakis, G., Susman, R. D., Inglis, G., Gardener, G., Buckley, M. F., Roscioli, T. Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 lys650met mutation. Am. J. Med. Genet. 146A: 212-218, 2008. [PubMed: 18076102] [Full Text: https://doi.org/10.1002/ajmg.a.32085]


Creation Date:
Carol A. Bocchini : 7/24/2015

Edit History:
alopez : 06/16/2023
carol : 07/26/2015
carol : 7/24/2015